Industry Wants More Details On Obama’s Precision Medicine Initiative
This article was originally published in The Gray Sheet
Executive Summary
The president announced a new plan before Congress that could bolster federal funding for diagnostics and personalized medicine. Industry commended the administration’s move but was also cautious due to the lack of detail and says it wants to be at the drawing table when specifics are put to paper.
You may also be interested in...
Administration Dismisses Industry Link Between Precision Medicine Initiative And Device Tax
The White House does not see a connection between President Obama’s call to increase federal funding for medical research and industry push to drop the medical device tax to funnel more money into R&D. However, the administration says it is open to discussing the tax with the new Republican Congress.
Obama Wants $215 Million Infusion For Precision Medicine
The president provided details on his administration's Precision Medicine Initiative, including funds to sequence at least a million new whole genomes and update FDA’s oversight of next-generation genome sequencing.
Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus
The House Energy and Commerce Committee is seeking feedback on legislative initiatives Congress should enact in 2015 regarding regulation of diagnostics, and in particular in response to FDA's plan to regulate laboratory developed tests.